Back to Agenda
Closing
Speaker(s)
Closing Remarks
Sara Torgal, MPharm
, European Medicines Agency (EMA), Netherlands
Closing Remarks
Mats G. Hansson
IMI PREFER Coordinator & Senior Professor of Biomedical Ethics, Uppsala University, Sweden
Closing Remarks
Conny Berlin, MS
IMI PREFER Project Leader & Global Head, Quantitative Safety and Epidemiology, Novartis Pharma AG, Switzerland
Have an account?